Image caption: By the end of the trial, 60% of patients were able to effectively stop Donanemab treatment. Image credit:...
FDA
Image caption: A unique once-a-day pill to treat ALS has been approved for ongoing clinical trials. Image credit: Depositphotos. Article...
Photo credit: Max Buondonno / ZDNET. Article by Don Reisinger. ZDNET - May 3, 2024. Apple has made clear that...
Image credit: Hugo Abad / Moment / Getty Images. Article by Nicole Karlis, Salon. Truthout - April 26, 2024. For...
Image caption: The CDC and FDA are investigating reports of patients in nearly a dozen U.S. states being injected with...
